Maxlinear MXL
- Market cap
- $5.8B
- PE
- n/m
- a loss over the last year
- Forward PE
- n/m
- not a meaningful number
- Price to sales
- 10.1×
- EV/EBIT
- n/m
- a loss over the last year
- Revenue, 12 months
- $568.9M
- +51% on a year ago
- Net margin
- −18.2%
- Free cash flow yield
- 0.1%
Maxlinear trades at 10.1× sales. Its trailing earnings are negative, so it has no PE. Revenue was $568.9M over the last twelve months, up 51% on a year earlier with a −18% net margin.
Charts
Financials
| Income statement | Q3 FY23 | Q4 FY23 | Q1 FY24 | Q2 FY24 | Q3 FY24 | Q4 FY24 | Q1 FY25 | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| $135.5M−53% | $125.4M−57% | $95.3M−62% | $92M−50% | $81.1M−40% | $92.2M−27% | $95.9M+1% | $108.8M+18% | $126.5M+56% | $136.4M+48% | $137.2M+43% | $168.8M+55% | |
| Cost of revenue | $61.6M−48% | $56.8M−55% | $46M−58% | $41.8M−48% | $37M−40% | $40.9M−28% | $42.1M−9% | $47.3M+13% | $54.6M+47% | $57.9M+41% | $58.3M+39% | $71.2M+51% |
| Gross profit | $73.9M−56% | $68.5M−58% | $49.3M−65% | $50.2M−51% | $44.1M−40% | $51.2M−25% | $53.8M+9% | $61.5M+23% | $71.9M+63% | $78.6M+53% | $78.9M+47% | $97.7M+59% |
| R&D | $66.3M−13% | $65.3M−12% | $64.8M−4% | $56.5M−20% | $52.6M−21% | $51.3M−21% | $55.5M−14% | $47.2M−17% | $54.3M+3% | $51.7M+1% | $53.2M−4% | $56M+19% |
| SG&A | $25.4M−34% | $34.4M−23% | $36.5M−6% | $33.6M−0% | $30.2M+19% | $38.1M+11% | $36.6M+0% | $33.4M−1% | $47.7M+58% | $42M+10% | $42.5M+16% | $45.8M+37% |
| −$17.8M | −$41.7M | −$74.6M | −$40.8M+588% | −$66.7M+275% | −$41.2M−1% | −$46.1M−38% | −$24.6M−40% | −$41.3M−38% | −$14.9M−64% | −$17.2M−63% | −$4.2M−83% | |
| Interest expense | $2.7M+0% | $2.9M+27% | $2.7M+9% | $2.7M+4% | $2.7M−2% | $2.8M−4% | $2.5M−8% | $2.5M−7% | $2.6M−0% | $2.4M−15% | $2.2M−12% | $2.3M−10% |
| Pre-tax income | −$41.5M | −$42.6M | −$74.1M | −$41.3M+768% | −$82.5M+99% | −$40.8M−4% | −$49M−34% | −$30.7M−26% | −$43.4M−47% | −$17.8M−56% | −$18.7M−62% | −$6.5M−79% |
| −$1.7M | −$4.1M | −$1.8M | −$2.1M+404% | −$6.7M+298% | $17M | $711K | −$4.1M+100% | $2.1M | −$2.9M | $26.5M+3625% | −$8.3M+102% | |
| Net income | −$39.8M | −$38.5M | −$72.3M | −$39.3M+803% | −$75.8M+90% | −$57.8M+50% | −$49.7M−31% | −$26.6M−32% | −$45.5M−40% | −$14.9M−74% | −$45.1M−9% | $1.8M |
| −$0.49 | −$0.47 | −$0.88 | −$0.47+840% | −$0.90+84% | −$0.68+45% | −$0.58−34% | −$0.31−34% | −$0.52−42% | −$0.17−75% | −$0.52−10% | $0.02 | |
| 81.2M+2% | 81.7M−1% | 82.3M+1% | 83.5M+4% | 84.1M+4% | 84.5M+3% | 85.3M+4% | 86.6M+4% | 87.2M+4% | 87.2M+3% | 87.6M+3% | 97.3M+12% |
EPS, diluted: 9 periods, Q4 FY10 to Q4 FY25: quarter's net income to common over its shares, to the cent.
Diluted shares: 5 periods, Q4 FY10 to Q4 FY22: share-days: the 12-month average less the 9-month, weighted by days. 11 periods, Q4 FY11 to Q4 FY25: a loss quarter: its basic count, share-days: the 12-month average less the 9-month, weighted by days.
From each company's 10-Q and 10-K filings, the newest version of each figure. Quarters are as filed (a fourth quarter is the year less its first nine months), fiscal years as the 10-K prints them, restated where a later 10-K restated them, and balance sheet lines as of the period's end. A quarter whose 10-Q isn't filed yet is from the company's results release. Growth is on the same period a year earlier. A dash is a period with no figure for the line: the filing doesn't print it, or it hasn't been read yet.
Peers
Companies in Semiconductors nearest Maxlinear's size, closest first.
| Company | Market cap | PE | Its 10y median PE | Fwd PE | P/S | Revenue growth | Net margin |
|---|---|---|---|---|---|---|---|
| MXLMaxlinear | $5.8B | n/m | 33.6× | 10.1× | +51% | −18.2% | |
| CRUSCirrus Logic | $5.6B | 13.7× | 21.2× | 2.7× | +6% | 21.0% | |
| FORMFormfactor | $7.7B | 67.5× | 40.5× | 8.5× | +18% | 12.8% | |
| ENPHEnphase Energy | $4.2B | 31.9× | 74.6× | 3.1× | −10% | 10.1% | |
| KLICKulicke & Soffa Industries | $3.9B | 34.0× | 26.5× | 4.1× | +44% | 12.2% | |
| DIODDiodes | $3.7B | 43.8× | 30.7× | 2.3× | +18% | 5.3% | |
| RMBSRambus | $9.3B | 39.3× | 45.4× | 12.3× | +17% | 31.7% | |
| ACMRACM Research | $3.5B | 24.0× | 26.0× | 3.4× | +27% | 14.5% | |
| AMKRAmkor Technology | $9.8B | 17.6× | 14.5× | 1.3× | +18% | 7.4% | |
| ACLSAxcelis Technologies | $3.3B | 35.8× | 23.1× | 3.8× | −3% | 10.7% | |
| PENGPenguin Solutions | $3.2B | 22.0× | 69.8× | 1.9× | +26% | 10.4% | |
| Peer median | $4B | 32.9× | 28.6× | 3.3× | +18% | 11.4% |
Investors who own it
Investors we follow who held Maxlinear at the end of Jun 30, 2026, from their 13F filings.
- Lee AinslieMaverick Capital0.0% of portfolionew
More on Maxlinear
Each number over time
- PE ratio
- Price to sales ratio
- EV/EBIT
- Price to free cash flow
- Price to book ratio
- Market cap
- Revenue
- EPS
- Free cash flow
- Profit margin
- Shares outstanding
Its groups
About
- Industry
- Semiconductors
- Sector
- Technology
Valuation data, not investment advice. Prices as of .